What's next in carbon ion radiotherapy at NIRS?

Since its launch by the National Institute of Radiological Sciences (NIRS) in 1994, cancer therapy using heavy ion beams (carbon ion beams) has been used in approximately 5,500 patients. Accumulated clinical experience has identified certain types of malignant tumors that respond exclusively to this treatment. It has also been made clear that this therapy is capable of treating several other types of cancers safely in a relatively short period of time, effecting remission and/or cure without pain or discomfort in a few days or weeks. We can reasonably state that heavy ion radiotherapy has been established as a safe and effective treatment method. NIRS researchers are continuing to make every effort to develop more effective, efficient, and patient-friendly heavy ion irradiation systems. The result of this research and development is also expected to slash the attendant costs of heavy ion radiotherapy. (author)